From: Characterization of patients that can continue conservative treatment for adenomyosis
 | Group A (n = 28) | Group B (n = 26) | p value |
---|---|---|---|
Age†| 43 (33–53) | 37 (27–46) | < 0.001 |
Gravida†| 2 (0–6) | 0 (0–3) | < 0.001 |
Parity†| 2 (0–3) | 0 (0–2) | < 0.001 |
Multipara†| 23 (82.1%) | 11 (42.3%) | < 0.001 |
Long axis diameter (cm)* | 11.1 (7.6–17.7) | 9.0 (6.4–13.0) | < 0.001 |
Short axis diameter (cm)* | 7.7 (4.7–12.9) | 6.0 (3.5–9.9) | 0.002 |
Transvers diameter (cm)* | 8.0 (4.1–14.2) | 6.6 (3.7–9.2) | 0.012 |
Muscle layer thickness (cm)* | 4.6 (2.5–7.3) | 3.5 (1.3–6.4) | 0.018 |
Type IV adenomyosis* | 18 (64.3%) | 10 (38.5%) | 0.059 |
Another of endometriosis* | 11 (39.3%) | 13 (50.0%) | 0.766 |